DAC MEETING OUTCOME
DAC meetings are held quarterly each year to evaluate new drug applications for listing in the HA Drug Formulary. DAC’s Recommendation will be sent to the concerned Cluster / Hospital DTCs after the DAC meetings. The recommended drugs will be posted in the web after the meetings and the recommended drugs will be listed on the HA Drug Formulary in around two months after the meetings.
DAC meeting outcomes in the past 3 years are set out below:-
May 2025 meeting (Outcomes)
Feb 2025 meeting (Outcomes)
Oct 2024 meeting (Outcomes)
Jul 2024 meeting (Outcomes)
Apr 2024 meeting (Outcomes)
Jan 2024 meeting (Outcomes)
Oct 2023 meeting (Outcomes)
Jul 2023 meeting (Outcomes)
Apr 2023 meeting (Outcomes)
Jan 2023 meeting (Outcomes)
Oct 2022 meeting (Outcomes)
Jul 2022 meeting (Outcomes)